Core Insights - The single License-out transaction amount has surpassed $3 billion, and the total overseas transaction amount for the year is approaching $100 billion, indicating that Chinese innovative drugs have quietly entered the "hard currency" era [1][3] - This surge in transaction volume signals a systematic rise of the Chinese pharmaceutical industry within the global value chain, driven by qualitative changes in R&D capabilities and strategic vision [1][3] Industry Challenges - Key questions need to be clarified amidst the excitement: Is the explosion of transactions an偶然 or a必然? What are the deep drivers behind the $92.03 billion figure? [2][4] - How can leading companies transition from "selling rights" to "co-creating"? [2][4] - How can small and medium-sized pharmaceutical companies avoid the red ocean and find their own "small but beautiful" pathways for overseas expansion? [2][4] - In the face of valuation bubbles and negotiation games, how can companies scientifically grasp the timing of licensing and anchor fair prices? [2][4] Event Announcement - On December 17, a live session titled "New Drug Relativity" will be co-hosted by Yaoduo and Boji Pharmaceutical, addressing these core issues with industry experts [2][4][5] - The session will feature Wan Jin, founding partner of Yuanjin Venture Capital, James Li, Vice President of Business Development at BIOTrialMed, and Ding Hongxia, co-founder of Yaoduo, to explore the core dynamics and future directions of the globalization of Chinese innovative drug value [2][4][5] Company Overview - Yaoduo is a "drug research and development intelligent innovation service platform" driven by big data and deep intelligence interpretation [3][5] - Since its establishment, Yaoduo has focused on integrating advanced IT technologies such as big data, knowledge graphs, and artificial intelligence with pharmaceutical professional knowledge, building a robust pharmaceutical big data collection system [3][5] - With over 10 years of accumulation, Yaoduo possesses a vast data lake/warehouse (500TB) and has developed unique algorithms for deep trend prediction and opportunity recommendation, empowering decision-making and innovation in the pharmaceutical industry [3][5]